Evidence map›Paper›PMID 35515124›Full record

ArticleFrontiers in oncology2022

Bone Marrow-Derived Stem Cell Factor Regulates Prostate Cancer-Induced Shifts in Pre-Metastatic Niche Composition.

Brittni M Foster, Lihong Shi, Koran S Harris, Chirayu Patel, Victoria E Surratt, Kendall L Langsten, Bethany A Kerr

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brittni M FosterDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Lihong ShiDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Koran S HarrisDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Chirayu PatelDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Victoria E SurrattDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Kendall L LangstenDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Bethany A KerrDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Wake Forest University · USWake Forest Baptist Comprehensive Cancer Center

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Laboratory Animal & Comparative Medicine TrainingT32OD010957 · OD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI J. MARK CLINE · 2012 to 2026
$4.3M
CD117 Signaling as a Mechanism of Prostate Cancer MetastasisR00CA175291 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KERR, BETHANY AMBER · 2016 to 2018
$722k
NCATS NIH HHS UL1 TR001420NCI NIH HHS P30 CA012197NCI NIH HHS R00 CA175291NIH HHS T32 OD010957
6 · The paper itself

Abstract

Skeletal metastasis is the leading cause of morbidity and mortality in prostate cancer, with 80% of advanced prostate cancer patients developing bone metastases. Before metastasis, bone remodeling occurs, stimulating pre-metastatic niche formation and bone turnover, and platelets govern this process. Stem cell factor (SCF, Kit Ligand) is increased in advanced prostate cancer patient platelet releasates. Further, SCF and its receptor, CD117/c-kit, correlate with metastatic prostate cancer severity. We hypothesized that bone-derived SCF plays an important role in prostate cancer tumor communication with the bone inducing pre-metastatic niche formation. We generated two cell-specific SCF knockout mouse models deleting SCF in either mature osteoblasts or megakaryocytes and platelets. Using two syngeneic androgen-insensitive murine prostate cancer cell lines, RM1 (

Indexed as

bone microenvironmentCD117/c-kitosteoblastplateletprostate cancerstem cell factor

Identifiers

PMID35515124
PMCPMC9063312
OpenAlexW4285745340

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.